Concepedia

María Solé Rodriguez

MS

Statistics

Publications

5

Citations

298

H-Index

5

Active since

2014

Affiliations

Hospital Universitario Virgen del Rocío(Current)

Instituto de Biomedicina de Sevilla

Universidad de Sevilla

Hospital Jerez Puerta del Sur

María Solé Rodriguez is an author at Hospital Universitario Virgen del Rocío specializing in medicine, lymphoid tumors, and cell signaling.

Publications per year

2014–2017

5

Publications

5

PP2A Inhibition Is a Common Event in Colorectal Cancer and Its Restoration Using FTY720 Shows Promising Therapeutic Potential

Ion Cristóbal, Rebeca Manso, Raúl Rincón et al. · Molecular Cancer Therapeutics · 2014 · 125 citations · Full text

, , +17

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia

Rachel Thijssen, Johanna ter Burg, Brett Garrick et al. · Blood · 2016 · 70 citations · Full text

, , +14

Role of 18F‐FDG‐PET/CT in the management of marginal zone B cell lymphoma

Estrella Carrillo‐Cruz, V. Marín-Oyaga, Fátima de la Cruz Vicente et al. · Hematological Oncology · 2014 · 48 citations

, , +12

Role of 18F‐<scp>FDG</scp>‐<scp>PET</scp>/<scp>CT</scp> in the management of Burkitt lymphoma

Estrella Carrillo‐Cruz, V. Marín-Oyaga, María Solé Rodriguez et al. · European Journal Of Haematology · 2014 · 37 citations

, , +13

Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia

Joaquín Sánchez‐García, José Falantes, Ángeles Medina Perez et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2017 · 18 citations

, , +15

1–5 of 5